Peregrine Pharmaceuticals, Inc. (Peregrine) is a clinical-stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection. The Company is advancing three separate clinical programs with its compounds bavituximab and Cotara... more

Cytogen Corporation of Princeton, NJ is a product-driven, oncology-focused biopharmaceutical company. Cytogen markets proprietary and licensed oncology products through its in-house specialty sales force: Quadramet® (a skeletal targeting therapeutic radiopharmaceutical for the relief of... more

Biomira is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Biomira's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes... more

Miraculins was founded by Dr. Phiet Bui and Dr. Albert Friesen as a result of their collective interest in exploring the macromolecular profiles of bodily fluids as evidence of an individual's state of health. The Company began operations in 2002 when scientific and financial resources... more

Genetix was founded by Mark Reid, its current Chief Executive, in 1991 to design and manufacture equipment and consumables for use in genomic research. Genetix has evolved by developing and launching innovative products to address the increasing demand for faster genetic research... more

Immunicon is developing and commercializing diagnostic and research products for rare cell analysis, with an initial focus on cancer. Reagent kits incorporating Immunicon proprietary technology are used with our instrument systems to capture, count and characterize circulating tumor cells... more

Molecular Insight Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of molecular imaging pharmaceuticals and targeted radiotherapeutics designed to improve patient diagnosis, treatment and management. During the year ended... more

Biotherapies is focused on the development of Mammastatin, a growth inhibitory protein that is being commercialized as a potential therapy for breast cancer.

Rubicon is committed to the development of highly sensitive and specific non-invasive tests for cancer using its proprietary MethylPlex technology. The MethylPlex tests will initially focus on serum and urine samples, since these are universally available fluids that contain very small... more

InterGenetics® is a personalized medicine company focused on molecular diagnostics and targeted therapy for cancer. An innovator in the frontier of genetic medicine, InterGenetics® research discovered CombiSNP®, proprietary gene combinations and DNA assessment technology leading to... more

Correlogic and Johns Hopkins University enter into a collaborative research agreement to develop computational diagnostic models of inflammatory vascular diseases. Using Correlogic's proprietary software and processes, researchers will attempt to identify patients with specific... more

Variagenics, Inc. develops molecular diagnostic tests by identifying genetic markers associated with response to cancer therapies, with the goal of optimizing patient care. The Company analyzes genetic variation, including single nucleotide polymorphisms (SNPs), haplotypes, loss of... more

MolecularMD provides the highest quality, most informative molecular diagnostic products and services for the diagnosis and monitoring of personalized medicine. The company is currently focused on oncology and looking for successful candidates with experience in the development of DNA and... more

CeMines was founded in 2000 by Richard Cavalli, Toomas Neuman and Kaia Palm to develop cancer diagnostics using two methods: auto-antibody and splice variant technologies.

BioCurex, Inc. is a biotechnology company that is developing products based on patented/proprietary technology in the areas of cancer diagnosis, imaging and therapy.

Almac has the most comprehensive range of integrated drug development services available to the biopharmaceutical industry. Employing over 2,000 highly skilled individuals, the privately owned company is headquartered in Craigavon, Northern Ireland and has extensive facilities in the UK... more

Orion Genomics develops oncology diagnostic products for cancer screening and therapy selection. We leverage our suite of proprietary technologies to find and interpret normal and abnormal epigenetic patterns of DNA methylation, also known as DNA's Second Code. We are currently... more

Founded in 1999 and based in Watertown, Mass., Pintex Pharmaceuticals, Inc. (www.pintexpharm.com) is a private pharmaceuticals company engaged in the discovery and development of structure-based cancer therapeutics that are based on its exclusive rights to technology which originated at... more

We are committed to clinical excellence. Onconome, Inc. is an in-vitro diagnostics company focusing on the discovery, development and commercialization of innovative biomarkers for the early and accurate detection of various forms of cancer and other major diseases with unmet... more

Auvation is a privately-held Scottish biotechnology company dedicated to the development of innovative technologies for the diagnosis and treatment of cancer. The company was formed in 1996 by Dr Bill Melvin, who was at that time engaged in academic research into tumour-specific... more

Predictive Biosciences is a molecular diagnostics company headquartered in Lexington, MA. Launched in 2006 with a $10 million Series A financing, the company was jointly founded by leading healthcare investors, experienced entrepreneurs, and internationally-renowned scientists in the... more

Cangen Biotechnologies is developing the next generation of early cancer diagnostics and designing chemo-sensitivity methods for the selection of optimal cancer therapies.

BIOCARE MEDICAL is a unique manufacturer and supplier of immunohistochemical and histopathology products, monoclonal and polyclonal antibodies, and automated staining equipment. We are continually researching the most innovative and cost-effective diagnostic solutions and state-of-the-art... more

TMD provides oncology biomarker services for the pharmaceutical and biotechnology industries. We work with our clients to help them design effective clinical trials that reduce the time and cost of bringing a drug to market. TMD has extensive scientific background in biomarker... more

Biotron Limited (Biotron) is an Australia-based company. The principal activities of the Company are funding and management of intermediate and applied biotechnology research and development projects. During the fiscal year ended June 30, 2008 (fiscal 2008), the Company completed the... more

Dermagene Oy is a novel biotech company founded in 2005. Dermagene was established on the breakthrough findings of NAV3 gene aberrations in cancer cells, first detected in cutaneous T-cell lymphoma (CTCL) and later in various other cancer types (eg. gliomas, breast cancer, colon cancer,... more

Egenix has executed a definitive agreement with ABT Genetic Engineering Company for creation of a joint venture to complete development and commercialization of single chain multivalent antibodies for cancer therapeutics. The single chain multivalent antibody technology is a uniquely... more